ORPHAI Trademark

Trademark Overview

On Friday, September 29, 2023, a trademark application was filed for ORPHAI with the United States Patent and Trademark Office. The USPTO has given the ORPHAI trademark a serial number of 98203856. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, May 17, 2024. This trademark is owned by OrphAI Therapeutics Inc.. The ORPHAI trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:

Recorded computer software featuring deep learning algorithms and AI for pharmaceutical, medical, scientific, and biopharmaceutical research and development and analysis, none of the foregoing for design, test and implementation

Medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases; Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases, namely, Amyotrophic Lateral Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Sarcoidosis, Bronchiolitis Obliterans; Pharmaceutical and biopharmaceutical preparations for the treatment of cancer and rare diseases, namely, Amyotrophic Lateral Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Sarcoidosis, Bronchiolitis Obliterans; Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases; Pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer and rare diseases; Pharmaceutical, medical, scientific, and biopharmaceutical research and development

Development of pharmaceutical preparations and medicines; Genetic engineering; Laboratory research in the field of gene expression; Medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases; Medical, pharmaceutical, and biopharmaceutical research services; Non-downloadable computer software featuring deep learning algorithms and AI for pharmaceutical, medical, scientific, and biopharmaceutical research and development and analysis; Pharmaceutical, medical, scientific, and biopharmaceutical research and development; Providing medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases; Providing research and development relating to pharmaceutical, medical, scientific, an...
orphai

General Information

Serial Number98203856
Word MarkORPHAI
Filing DateFriday, September 29, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, May 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesRecorded computer software featuring deep learning algorithms and AI for pharmaceutical, medical, scientific, and biopharmaceutical research and development and analysis, none of the foregoing for design, test and implementation
Goods and ServicesMedical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases; Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases, namely, Amyotrophic Lateral Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Sarcoidosis, Bronchiolitis Obliterans; Pharmaceutical and biopharmaceutical preparations for the treatment of cancer and rare diseases, namely, Amyotrophic Lateral Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Sarcoidosis, Bronchiolitis Obliterans; Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases; Pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer and rare diseases; Pharmaceutical, medical, scientific, and biopharmaceutical research and development
Pseudo MarkORPH ARTIFICIAL INTELLIGENCE
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Genetic engineering; Laboratory research in the field of gene expression; Medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases; Medical, pharmaceutical, and biopharmaceutical research services; Non-downloadable computer software featuring deep learning algorithms and AI for pharmaceutical, medical, scientific, and biopharmaceutical research and development and analysis; Pharmaceutical, medical, scientific, and biopharmaceutical research and development; Providing medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases; Providing research and development relating to pharmaceutical, medical, scientific, and biopharmaceutical; Research in the field of gene therapy; Scientific and medical research in the fields of gene, genome, and genomic editing, modulation, transcription, to develop human pharmaceutical and biopharmaceutical preparations; Scientific research for medical purposes in the field of cancerous diseases; Scientific research in the field of genetics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOrphAI Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGuilford, CT 06437

Trademark Events

Event DateEvent Description
Friday, May 17, 2024NON-FINAL ACTION WRITTEN
Friday, May 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 17, 2024NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, August 14, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, May 7, 2024ASSIGNED TO EXAMINER
Tuesday, October 3, 2023NEW APPLICATION ENTERED
Thursday, October 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

orphai pharmaceutical research biopharmaceutical medical scientific gene diseases genome modulation editing